<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00873496</url>
  </required_header>
  <id_info>
    <org_study_id>EAlpoz 1</org_study_id>
    <nct_id>NCT00873496</nct_id>
  </id_info>
  <brief_title>Effects of Hydroxychloroquine on Oral Complaints of Sjögren Patients</brief_title>
  <official_title>Effects of Hydroxychloroquine on Oral Complaints of Sjögren Patients: a Prospective Sample Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ege University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ege University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic inflammation that comprises the exocrine glands' function leads to xerophthalmia and
      xerostomia in Sjögren's syndrome. The oral consequences range widely and they are related to
      decreased salivary output. Hydroxychloroquine may inhibit cholinesterase activity in salivary
      glands via interference with antigen processing mechanism, and thus, the investigators'
      hypothesis was that salivary gland function may be improved if treated with
      hydroxychloroquine. The effects of hydroxychloroquine on the salivary flow rate, subjective
      and objective parameters of the patients were also assessed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2005</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Salivary flow rate, objective and subjective clinical oral complaints</measure>
    <time_frame>2005 Jan-2009 Jan</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Sjögren's Syndrome</condition>
  <condition>Xerostomia</condition>
  <arm_group>
    <arm_group_label>Sjögren</arm_group_label>
    <description>Pre and post treatment establishment of salivary flow rate, objective and subjective clinical oral complications' severity of the patients using hydroxychloroquine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxychloroquine</intervention_name>
    <arm_group_label>Sjögren</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study group consisted of 30 female patients recently diagnosed as Sjögren's syndrome.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who were recently diagnosed with primary SS according to American-European
             criteria and who were scheduled for HCQ treatment in Ege University Faculty of
             Medicine, Department of Rheumatology

        Exclusion Criteria:

          -  Sjögren patients consuming alcohol or tobacco
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Esin Alpoz</last_name>
    <role>Study Director</role>
    <affiliation>Ege University School of Dentistry</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ege University School of Dentistry</name>
      <address>
        <city>Izmir</city>
        <state>Bornova</state>
        <zip>35100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Alpöz E, Güneri P, Onder G, Cankaya H, Kabasakal Y, Köse T. The efficacy of Xialine in patients with Sjögren's syndrome: a single-blind, cross-over study. Clin Oral Investig. 2008 Jun;12(2):165-72. Epub 2007 Nov 14.</citation>
    <PMID>18000691</PMID>
  </reference>
  <results_reference>
    <citation>Kruize AA, Hené RJ, Kallenberg CG, van Bijsterveld OP, van der Heide A, Kater L, Bijlsma JW. Hydroxychloroquine treatment for primary Sjögren's syndrome: a two year double blind crossover trial. Ann Rheum Dis. 1993 May;52(5):360-4.</citation>
    <PMID>8323383</PMID>
  </results_reference>
  <results_reference>
    <citation>Dawson LJ, Caulfield VL, Stanbury JB, Field AE, Christmas SE, Smith PM. Hydroxychloroquine therapy in patients with primary Sjögren's syndrome may improve salivary gland hypofunction by inhibition of glandular cholinesterase. Rheumatology (Oxford). 2005 Apr;44(4):449-55. Epub 2004 Dec 8.</citation>
    <PMID>15590764</PMID>
  </results_reference>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2009</study_first_submitted>
  <study_first_submitted_qc>March 31, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2009</study_first_posted>
  <last_update_submitted>March 31, 2009</last_update_submitted>
  <last_update_submitted_qc>March 31, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 1, 2009</last_update_posted>
  <responsible_party>
    <name_title>Esin Alpoz</name_title>
    <organization>Ege University School of Dentistry</organization>
  </responsible_party>
  <keyword>Sjögren's Syndrome</keyword>
  <keyword>hyposalivation</keyword>
  <keyword>mouth dryness</keyword>
  <keyword>complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sjogren's Syndrome</mesh_term>
    <mesh_term>Xerostomia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydroxychloroquine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

